135 related articles for article (PubMed ID: 8986292)
1. Expression of heat shock protein 70 (HSP70) and EBV latent membrane protein 1 (LMP1) in Reed-Sternberg cells of Hodgkin's disease.
Takahashi H; Fujita S; Shibata Y; Tsuda N; Okabe H
Anal Cell Pathol; 1996 Nov; 12(2):71-83. PubMed ID: 8986292
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
Pinkus GS; Lones M; Shintaku IP; Said JW
Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.
Kanavaros P; Sakalidou A; Gaulard P; Jiwa M; Delides G; Tzardi M; Kalmantis T; Lydaki E; Kazlaris E; Kalmanti M
Acta Morphol Hung; 1992; 40(1-4):223-30. PubMed ID: 1365766
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells.
Weinreb M; Day PJ; Murray PG; Raafat F; Crocker J; Parkes SE; Coad NA; Jones JT; Mann JR
J Pathol; 1992 Dec; 168(4):365-9. PubMed ID: 1336543
[TBL] [Abstract][Full Text] [Related]
5. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients.
Audouin J; Diebold J; Pallesen G
J Pathol; 1992 Aug; 167(4):381-4. PubMed ID: 1328576
[TBL] [Abstract][Full Text] [Related]
6. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease.
Murray PG; Young LS; Rowe M; Crocker J
J Pathol; 1992 Jan; 166(1):1-5. PubMed ID: 1311374
[TBL] [Abstract][Full Text] [Related]
8. [High prevalence of the Epstein-Barr virus in a Mexican population with Hodgkin's disease].
Quintanilla-Martínez L; Gamboa-Domínguez A; Gámez-Ledesma I; Orozco-Estévez H; Angeles-Angeles A
Rev Invest Clin; 1994; 46(5):355-62. PubMed ID: 7839015
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.
Kordek R; Biernat W; Kupnicka D; Woźniak L
Pol J Pathol; 1994; 45(4):279-81. PubMed ID: 7697330
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
Coles FB; Cartun RW; Pastuszak WT
Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
12. CD40 expression in Hodgkin's disease.
O'Grady JT; Stewart S; Lowrey J; Howie SE; Krajewski AS
Am J Pathol; 1994 Jan; 144(1):21-6. PubMed ID: 7507299
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease.
Carbone A; Gloghini A; Zanette I; Canal B; Rizzo A; Volpe R
Virchows Arch A Pathol Anat Histopathol; 1993; 422(1):39-45. PubMed ID: 7679848
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis.
Isaacson PG; Schmid C; Pan L; Wotherspoon AC; Wright DH
J Pathol; 1992 Jul; 167(3):267-71. PubMed ID: 1381432
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
Pinkus GS; Said JW
Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
Frierson HF; Innes DJ
Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
[TBL] [Abstract][Full Text] [Related]
18. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.
Jiwa NM; Oudejans JJ; Bai MC; Van den Brule AJ; Horstman A; Vos W; Van der Valk P; Kluin PM; Walboomers JM; Meijer CJ
Histopathology; 1995 Jun; 26(6):547-53. PubMed ID: 7665145
[TBL] [Abstract][Full Text] [Related]
19. Absence of HLA class I expression by Reed-Sternberg cells.
Poppema S; Visser L
Am J Pathol; 1994 Jul; 145(1):37-41. PubMed ID: 7518195
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease.
Newcom SR; Gu L
J Clin Pathol; 1995 Feb; 48(2):160-3. PubMed ID: 7745117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]